Global Ponatinib Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 119923
  • calendar_today Published On: Mar, 2022
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Ponatinib market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Ponatinib market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. CML accounting for % of the Ponatinib global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While 45mg segment is altered to a % CAGR between 2022 and 2028.

Global key manufacturers of Ponatinib include ARIAD Pharmaceuticals, , , , and , etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Ponatinib market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

45mg

15mg

Market segment by Application can be divided into

CML

ALL

The key market players for global Ponatinib market are listed below:

ARIAD Pharmaceuticals

Market segment by region, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Ponatinib product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Ponatinib, with price, sales, revenue and global market share of Ponatinib from 2019 to 2022.

Chapter 3, the Ponatinib competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Ponatinib breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Ponatinib market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Ponatinib.

Chapter 13, 14, and 15, to describe Ponatinib sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Ponatinib Introduction

1.2 Market Analysis by Type

1.2.1 Overview: Global Ponatinib Revenue by Type: 2017 Versus 2021 Versus 2028

1.2.2 45mg

1.2.3 15mg

1.3 Market Analysis by Application

1.3.1 Overview: Global Ponatinib Revenue by Application: 2017 Versus 2021 Versus 2028

1.3.2 CML

1.3.3 ALL

1.4 Global Ponatinib Market Size & Forecast

1.4.1 Global Ponatinib Sales in Value (2017 & 2021 & 2028)

1.4.2 Global Ponatinib Sales in Volume (2017-2028)

1.4.3 Global Ponatinib Price (2017-2028)

1.5 Global Ponatinib Production Capacity Analysis

1.5.1 Global Ponatinib Total Production Capacity (2017-2028)

1.5.2 Global Ponatinib Production Capacity by Geographic Region

1.6 Market Drivers, Restraints and Trends

1.6.1 Ponatinib Market Drivers

1.6.2 Ponatinib Market Restraints

1.6.3 Ponatinib Trends Analysis

2 Manufacturers Profiles

2.1 ARIAD Pharmaceuticals

2.1.1 ARIAD Pharmaceuticals Details

2.1.2 ARIAD Pharmaceuticals Major Business

2.1.3 ARIAD Pharmaceuticals Ponatinib Product and Services

2.1.4 ARIAD Pharmaceuticals Ponatinib Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

3 Ponatinib Breakdown Data by Manufacturer

3.1 Global Ponatinib Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)

3.2 Global Ponatinib Revenue by Manufacturer (2019, 2020, 2021, and 2022)

3.3 Key Manufacturer Market Position in Ponatinib

3.4 Market Concentration Rate

3.4.1 Top 3 Ponatinib Manufacturer Market Share in 2021

3.4.2 Top 6 Ponatinib Manufacturer Market Share in 2021

3.5 Global Ponatinib Production Capacity by Company: 2021 VS 2022

3.6 Manufacturer by Geography: Head Office and Ponatinib Production Site

3.7 New Entrant and Capacity Expansion Plans

3.8 Mergers & Acquisitions

4 Market Analysis by Region

4.1 Global Ponatinib Market Size by Region

4.1.1 Global Ponatinib Sales in Volume by Region (2017-2028)

4.1.2 Global Ponatinib Revenue by Region (2017-2028)

4.2 North America Ponatinib Revenue (2017-2028)

4.3 Europe Ponatinib Revenue (2017-2028)

4.4 Asia-Pacific Ponatinib Revenue (2017-2028)

4.5 South America Ponatinib Revenue (2017-2028)

4.6 Middle East and Africa Ponatinib Revenue (2017-2028)

5 Market Segment by Type

5.1 Global Ponatinib Sales in Volume by Type (2017-2028)

5.2 Global Ponatinib Revenue by Type (2017-2028)

5.3 Global Ponatinib Price by Type (2017-2028)

6 Market Segment by Application

6.1 Global Ponatinib Sales in Volume by Application (2017-2028)

6.2 Global Ponatinib Revenue by Application (2017-2028)

6.3 Global Ponatinib Price by Application (2017-2028)

7 North America by Country, by Type, and by Application

7.1 North America Ponatinib Sales by Type (2017-2028)

7.2 North America Ponatinib Sales by Application (2017-2028)

7.3 North America Ponatinib Market Size by Country

7.3.1 North America Ponatinib Sales in Volume by Country (2017-2028)

7.3.2 North America Ponatinib Revenue by Country (2017-2028)

7.3.3 United States Market Size and Forecast (2017-2028)

7.3.4 Canada Market Size and Forecast (2017-2028)

7.3.5 Mexico Market Size and Forecast (2017-2028)

8 Europe by Country, by Type, and by Application

8.1 Europe Ponatinib Sales by Type (2017-2028)

8.2 Europe Ponatinib Sales by Application (2017-2028)

8.3 Europe Ponatinib Market Size by Country

8.3.1 Europe Ponatinib Sales in Volume by Country (2017-2028)

8.3.2 Europe Ponatinib Revenue by Country (2017-2028)

8.3.3 Germany Market Size and Forecast (2017-2028)

8.3.4 France Market Size and Forecast (2017-2028)

8.3.5 United Kingdom Market Size and Forecast (2017-2028)

8.3.6 Russia Market Size and Forecast (2017-2028)

8.3.7 Italy Market Size and Forecast (2017-2028)

9 Asia-Pacific by Region, by Type, and by Application

9.1 Asia-Pacific Ponatinib Sales by Type (2017-2028)

9.2 Asia-Pacific Ponatinib Sales by Application (2017-2028)

9.3 Asia-Pacific Ponatinib Market Size by Region

9.3.1 Asia-Pacific Ponatinib Sales in Volume by Region (2017-2028)

9.3.2 Asia-Pacific Ponatinib Revenue by Region (2017-2028)

9.3.3 China Market Size and Forecast (2017-2028)

9.3.4 Japan Market Size and Forecast (2017-2028)

9.3.5 Korea Market Size and Forecast (2017-2028)

9.3.6 India Market Size and Forecast (2017-2028)

9.3.7 Southeast Asia Market Size and Forecast (2017-2028)

9.3.8 Australia Market Size and Forecast (2017-2028)

10 South America by Region, by Type, and by Application

10.1 South America Ponatinib Sales by Type (2017-2028)

10.2 South America Ponatinib Sales by Application (2017-2028)

10.3 South America Ponatinib Market Size by Country

10.3.1 South America Ponatinib Sales in Volume by Country (2017-2028)

10.3.2 South America Ponatinib Revenue by Country (2017-2028)

10.3.3 Brazil Market Size and Forecast (2017-2028)

10.3.4 Argentina Market Size and Forecast (2017-2028)

11 Middle East & Africa by Country, by Type, and by Application

11.1 Middle East & Africa Ponatinib Sales by Type (2017-2028)

11.2 Middle East & Africa Ponatinib Sales by Application (2017-2028)

11.3 Middle East & Africa Ponatinib Market Size by Country

11.3.1 Middle East & Africa Ponatinib Sales in Volume by Country (2017-2028)

11.3.2 Middle East & Africa Ponatinib Revenue by Country (2017-2028)

11.3.3 Turkey Market Size and Forecast (2017-2028)

11.3.4 Egypt Market Size and Forecast (2017-2028)

11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)

11.3.6 South Africa Market Size and Forecast (2017-2028)

12 Raw Material and Industry Chain

12.1 Raw Material of Ponatinib and Key Manufacturers

12.2 Manufacturing Costs Percentage of Ponatinib

12.3 Ponatinib Production Process

12.4 Ponatinib Industrial Chain

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.2 Ponatinib Typical Distributors

13.3 Ponatinib Typical Customers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Research Process and Data Source

15.3 Disclaimer

List of Tables

Table 1. Global Ponatinib Revenue by Type, (USD Million), 2017 & 2021 & 2028

Table 2. Global Ponatinib Revenue by Application, (USD Million), 2017 & 2021 & 2028

Table 3. ARIAD Pharmaceuticals Basic Information, Manufacturing Base and Competitors

Table 4. ARIAD Pharmaceuticals Major Business

Table 5. ARIAD Pharmaceuticals Ponatinib Product and Services

Table 6. ARIAD Pharmaceuticals Ponatinib Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 7. Global Ponatinib Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)

Table 8. Global Ponatinib Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)

Table 9. Market Position of Manufacturers in Ponatinib, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021

Table 10. Global Ponatinib Production Capacity by Company, (K Units): 2020 VS 2021

Table 11. Head Office and Ponatinib Production Site of Key Manufacturer

Table 12. Ponatinib New Entrant and Capacity Expansion Plans

Table 13. Ponatinib Mergers & Acquisitions in the Past Five Years

Table 14. Global Ponatinib Sales by Region (2017-2022) & (K Units)

Table 15. Global Ponatinib Sales by Region (2023-2028) & (K Units)

Table 16. Global Ponatinib Revenue by Region (2017-2022) & (USD Million)

Table 17. Global Ponatinib Revenue by Region (2023-2028) & (USD Million)

Table 18. Global Ponatinib Sales by Type (2017-2022) & (K Units)

Table 19. Global Ponatinib Sales by Type (2023-2028) & (K Units)

Table 20. Global Ponatinib Revenue by Type (2017-2022) & (USD Million)

Table 21. Global Ponatinib Revenue by Type (2023-2028) & (USD Million)

Table 22. Global Ponatinib Price by Type (2017-2022) & (USD/Unit)

Table 23. Global Ponatinib Price by Type (2023-2028) & (USD/Unit)

Table 24. Global Ponatinib Sales by Application (2017-2022) & (K Units)

Table 25. Global Ponatinib Sales by Application (2023-2028) & (K Units)

Table 26. Global Ponatinib Revenue by Application (2017-2022) & (USD Million)

Table 27. Global Ponatinib Revenue by Application (2023-2028) & (USD Million)

Table 28. Global Ponatinib Price by Application (2017-2022) & (USD/Unit)

Table 29. Global Ponatinib Price by Application (2023-2028) & (USD/Unit)

Table 30. North America Ponatinib Sales by Country (2017-2022) & (K Units)

Table 31. North America Ponatinib Sales by Country (2023-2028) & (K Units)

Table 32. North America Ponatinib Revenue by Country (2017-2022) & (USD Million)

Table 33. North America Ponatinib Revenue by Country (2023-2028) & (USD Million)

Table 34. North America Ponatinib Sales by Type (2017-2022) & (K Units)

Table 35. North America Ponatinib Sales by Type (2023-2028) & (K Units)

Table 36. North America Ponatinib Sales by Application (2017-2022) & (K Units)

Table 37. North America Ponatinib Sales by Application (2023-2028) & (K Units)

Table 38. Europe Ponatinib Sales by Country (2017-2022) & (K Units)

Table 39. Europe Ponatinib Sales by Country (2023-2028) & (K Units)

Table 40. Europe Ponatinib Revenue by Country (2017-2022) & (USD Million)

Table 41. Europe Ponatinib Revenue by Country (2023-2028) & (USD Million)

Table 42. Europe Ponatinib Sales by Type (2017-2022) & (K Units)

Table 43. Europe Ponatinib Sales by Type (2023-2028) & (K Units)

Table 44. Europe Ponatinib Sales by Application (2017-2022) & (K Units)

Table 45. Europe Ponatinib Sales by Application (2023-2028) & (K Units)

Table 46. Asia-Pacific Ponatinib Sales by Region (2017-2022) & (K Units)

Table 47. Asia-Pacific Ponatinib Sales by Region (2023-2028) & (K Units)

Table 48. Asia-Pacific Ponatinib Revenue by Region (2017-2022) & (USD Million)

Table 49. Asia-Pacific Ponatinib Revenue by Region (2023-2028) & (USD Million)

Table 50. Asia-Pacific Ponatinib Sales by Type (2017-2022) & (K Units)

Table 51. Asia-Pacific Ponatinib Sales by Type (2023-2028) & (K Units)

Table 52. Asia-Pacific Ponatinib Sales by Application (2017-2022) & (K Units)

Table 53. Asia-Pacific Ponatinib Sales by Application (2023-2028) & (K Units)

Table 54. South America Ponatinib Sales by Country (2017-2022) & (K Units)

Table 55. South America Ponatinib Sales by Country (2023-2028) & (K Units)

Table 56. South America Ponatinib Revenue by Country (2017-2022) & (USD Million)

Table 57. South America Ponatinib Revenue by Country (2023-2028) & (USD Million)

Table 58. South America Ponatinib Sales by Type (2017-2022) & (K Units)

Table 59. South America Ponatinib Sales by Type (2023-2028) & (K Units)

Table 60. South America Ponatinib Sales by Application (2017-2022) & (K Units)

Table 61. South America Ponatinib Sales by Application (2023-2028) & (K Units)

Table 62. Middle East & Africa Ponatinib Sales by Region (2017-2022) & (K Units)

Table 63. Middle East & Africa Ponatinib Sales by Region (2023-2028) & (K Units)

Table 64. Middle East & Africa Ponatinib Revenue by Region (2017-2022) & (USD Million)

Table 65. Middle East & Africa Ponatinib Revenue by Region (2023-2028) & (USD Million)

Table 66. Middle East & Africa Ponatinib Sales by Type (2017-2022) & (K Units)

Table 67. Middle East & Africa Ponatinib Sales by Type (2023-2028) & (K Units)

Table 68. Middle East & Africa Ponatinib Sales by Application (2017-2022) & (K Units)

Table 69. Middle East & Africa Ponatinib Sales by Application (2023-2028) & (K Units)

Table 70. Ponatinib Raw Material

Table 71. Key Manufacturers of Ponatinib Raw Materials

Table 72. Direct Channel Pros & Cons

Table 73. Indirect Channel Pros & Cons

Table 74. Ponatinib Typical Distributors

Table 75. Ponatinib Typical Customers

List of Figures

Figure 1. Ponatinib Picture

Figure 2. Global Ponatinib Revenue Market Share by Type in 2021

Figure 3. 45mg

Figure 4. 15mg

Figure 5. Global Ponatinib Revenue Market Share by Application in 2021

Figure 6. CML

Figure 7. ALL

Figure 8. Global Ponatinib Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028

Figure 9. Global Ponatinib Revenue and Forecast (2017-2028) & (USD Million)

Figure 10. Global Ponatinib Sales (2017-2028) & (K Units)

Figure 11. Global Ponatinib Price (2017-2028) & (USD/Unit)

Figure 12. Global Ponatinib Production Capacity (2017-2028) & (K Units)

Figure 13. Global Ponatinib Production Capacity by Geographic Region: 2022 VS 2028

Figure 14. Ponatinib Market Drivers

Figure 15. Ponatinib Market Restraints

Figure 16. Ponatinib Market Trends

Figure 17. Global Ponatinib Sales Market Share by Manufacturer in 2021

Figure 18. Global Ponatinib Revenue Market Share by Manufacturer in 2021

Figure 19. Ponatinib Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021

Figure 20. Top 3 Ponatinib Manufacturer (Revenue) Market Share in 2021

Figure 21. Top 6 Ponatinib Manufacturer (Revenue) Market Share in 2021

Figure 22. Global Ponatinib Sales Market Share by Region (2017-2028)

Figure 23. Global Ponatinib Revenue Market Share by Region (2017-2028)

Figure 24. North America Ponatinib Revenue (2017-2028) & (USD Million)

Figure 25. Europe Ponatinib Revenue (2017-2028) & (USD Million)

Figure 26. Asia-Pacific Ponatinib Revenue (2017-2028) & (USD Million)

Figure 27. South America Ponatinib Revenue (2017-2028) & (USD Million)

Figure 28. Middle East & Africa Ponatinib Revenue (2017-2028) & (USD Million)

Figure 29. Global Ponatinib Sales Market Share by Type (2017-2028)

Figure 30. Global Ponatinib Revenue Market Share by Type (2017-2028)

Figure 31. Global Ponatinib Price by Type (2017-2028) & (USD/Unit)

Figure 32. Global Ponatinib Sales Market Share by Application (2017-2028)

Figure 33. Global Ponatinib Revenue Market Share by Application (2017-2028)

Figure 34. Global Ponatinib Price by Application (2017-2028) & (USD/Unit)

Figure 35. North America Ponatinib Sales Market Share by Type (2017-2028)

Figure 36. North America Ponatinib Sales Market Share by Application (2017-2028)

Figure 37. North America Ponatinib Sales Market Share by Country (2017-2028)

Figure 38. North America Ponatinib Revenue Market Share by Country (2017-2028)

Figure 39. United States Ponatinib Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 40. Canada Ponatinib Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 41. Mexico Ponatinib Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 42. Europe Ponatinib Sales Market Share by Type (2017-2028)

Figure 43. Europe Ponatinib Sales Market Share by Application (2017-2028)

Figure 44. Europe Ponatinib Sales Market Share by Country (2017-2028)

Figure 45. Europe Ponatinib Revenue Market Share by Country (2017-2028)

Figure 46. Germany Ponatinib Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 47. France Ponatinib Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 48. United Kingdom Ponatinib Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 49. Russia Ponatinib Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 50. Italy Ponatinib Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 51. Asia-Pacific Ponatinib Sales Market Share by Region (2017-2028)

Figure 52. Asia-Pacific Ponatinib Sales Market Share by Application (2017-2028)

Figure 53. Asia-Pacific Ponatinib Sales Market Share by Region (2017-2028)

Figure 54. Asia-Pacific Ponatinib Revenue Market Share by Region (2017-2028)

Figure 55. China Ponatinib Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 56. Japan Ponatinib Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 57. Korea Ponatinib Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 58. India Ponatinib Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 59. Southeast Asia Ponatinib Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 60. Australia Ponatinib Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 61. South America Ponatinib Sales Market Share by Type (2017-2028)

Figure 62. South America Ponatinib Sales Market Share by Application (2017-2028)

Figure 63. South America Ponatinib Sales Market Share by Country (2017-2028)

Figure 64. South America Ponatinib Revenue Market Share by Country (2017-2028)

Figure 65. Brazil Ponatinib Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 66. Argentina Ponatinib Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 67. Middle East & Africa Ponatinib Sales Market Share by Type (2017-2028)

Figure 68. Middle East & Africa Ponatinib Sales Market Share by Application (2017-2028)

Figure 69. Middle East & Africa Ponatinib Sales Market Share by Region (2017-2028)

Figure 70. Middle East & Africa Ponatinib Revenue Market Share by Region (2017-2028)

Figure 71. Turkey Ponatinib Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 72. Egypt Ponatinib Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 73. Saudi Arabia Ponatinib Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 74. South Africa Ponatinib Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 75. Manufacturing Cost Structure Analysis of Ponatinib in 2021

Figure 76. Manufacturing Process Analysis of Ponatinib

Figure 77. Ponatinib Industrial Chain

Figure 78. Sales Channel: Direct Channel vs Indirect Channel

Figure 79. Methodology

Figure 80. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

+1

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketquest.biz